Tvardi Therapeutics, Inc.
TVRD
$28.34
$1.706.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 83.75% | -29.43% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 86.06% | 1,494.44% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 83.86% | -25.97% | -- | ||
|
|
|||||
| Total Current Assets | 83.86% | -25.97% | -- | ||
| Net Property, Plant & Equipment | -9.45% | -8.33% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -4.07% | -4.16% | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -99.54% | 31.08% | -- | ||
| Total Assets | 57.32% | -20.99% | -- | ||
|
|
|||||
| Total Accounts Payable | 43.83% | -22.87% | -- | ||
| Total Accrued Expenses | 56.43% | -35.55% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 2.83% | 2.91% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 52.59% | -32.50% | -- | ||
|
|
|||||
| Total Current Liabilities | 52.59% | -32.50% | -- | ||
| Long-Term Debt | -- | 18.18% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -16.67% | -13.43% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -74.79% | 5.15% | -- | ||
|
|
|||||
| Common Stock & APIC | 10,892.26% | 7.51% | -- | ||
| Retained Earnings | 4.09% | -10.39% | -- | ||
| Treasury Stock & Other | -750.00% | -- | -- | ||
| Total Common Equity | 132.72% | -10.42% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 132.72% | -10.42% | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 317.74% | -168.69% | -- | ||
|
|
|||||